Award
NIH Reporter #5R01HL180429-02
NNMT Inhibition for treating heart failure
Recipient
University of California Los Angeles
Award Amount
$707,281.00
Ceiling
$707,281.00
Awarded
September 07, 2026
Identifier
5R01HL180429-02
NIH grant awarded to University of California Los Angeles for research on NNMT inhibition as a treatment for heart failure, with a project duration from August 2025 to May 2029 and an estimated value of $707,281.
Description
This is a NIH grant opportunity for research on inhibiting Nicotinamide-N-Methyl Transferase (NNMT) to treat heart failure. The project involves preclinical studies and aims to evaluate genetic and pharmacological inhibition of NNMT as a therapeutic strategy.